Novel Technologies to Overcome the Suppressive Tumor Microenvironment

Session 11: Novel Technologies to Overcome the Suppressive Tumor Microenvironment
Friday, November 5, 2021 | 10:50 AM – 12:15 PM PST

Moderator: Marco Gottardis, PhD, Janssen Research & Development, LLC

Introduction
Marco Gottardis, PhD, Janssen Research & Development, LLC

Improving CAR Responses against Solid Tumors with Conditional Payload Delivery
Gus Zeiner, PhD, Chimera Bioengineering

Combining Adenosine Pathway Inhibitors with Immunotherapy Agents in Prostate Cancer
Peter Fan, PhD, Teon Therapeutics

Mobilizing the Immune System with Bispecific Antibodies and Optimized Cytokines
John Desjarlais, PhD, Xencor

Microenvironment on Demand (MOD) – A Flexible Droplet-Microfluidic Platform to Accelerate Cell/Antibody Therapy Discoveries
Maithreyan Srinivasan, PhD, Scribe Biosciences

82 cents of every dollar donated goes to our prostate cancer research mission

Join the fight against prostate cancer today. Donate